";s:4:"text";s:4600:" These doses are, respectively, about 5 and 16 times the MRHD when compared on a mg/mIt is not known whether Nisoldipine is excreted in human milk. Nisoldipine extended-release tablets should be taken on an empty stomach (1 hour before or 2 hours after a meal).
Although 60% to 80% of an oral dose undergoes urinary excretion, only traces of unchanged Nisoldipine are found in urine. It is a calcium channel blocker of the dihydropyridine class. The plasma protein binding of Nisoldipine is very high, with less than 1% unbound over the plasma concentration range of 100 ng/mL to10 mcg/mL.Nisoldipine is highly metabolized; 5 major urinary metabolites have been identified. The major biotransformation pathway appears to be the hydroxylation of the isobutyl ester.
Nisoldipine is (±)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(Nisoldipine is a yellow crystalline powder, practically insoluble in water but soluble in acetone, ethanol and methanol. Ligand Activity Visualisation Charts These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Nó được cấp bằng sáng chế vào năm 1975 và được chấp thuận cho sử dụng y tế vào năm 1990. It is sold in the United States under the proprietary name Sular.
Find all the information about Nisoldipine (Sular) for cell signaling research. ]We comply with the HONcode standard for trustworthy health information - Quinidine at 648 mg bid decreased the bioavailability (AUC) of Nisoldipine by 26%, but not the peak concentration. The mean placebo-subtracted reductions in supine systolic and diastolic blood pressure at trough, 24 hours post-dose, in these studies, are shown below. Missan S, Zhabyeyev P, Dyachok O, Jones SE, McDonald TF (tháng 11 năm 2003). Their blood pressure should be monitored closely during any dosage adjustment. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. Doses beyond 60 mg once daily are not recommended. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy.More than 6000 patients world-wide have received Nisoldipine in clinical trials for the treatment of hypertension, either as the immediate release or the Nisoldipine extended-release formulation. Nisoldipine is (±)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate, C20 H24 N2 O6 , and has the structural formula:Nisoldipine is a yellow crystalline powder, practically insoluble in water but soluble in acetone, ethanol and methanol. Nisoldipine has tropism for cardiac blood vessels. In controlled studies of Nisoldipine extended-release tablets in patients with angina this was seen about 1.5% of the time in patients given Nisoldipine, compared with 0.9% in patients given placebo.Because Nisoldipine, like other vasodilators, decreases peripheral vascular resistance, careful monitoring of blood pressure during the initial administration and titration of Nisoldipine extended-release tablets is recommended. The effect of Nisoldipine on blood pressure is principally a consequence of a dose related decrease of peripheral vascular resistance. Nó được bán ở Hoa Kỳ dưới tên độc quyền Sular.Nisoldipine có tính nhiệt đối với các mạch máu tim. Select one or more newsletters to continue. Dose and plasma level related flattening or inversion of T-waves have been observed in a few small studies.
In pregnant rats, increased fetal resorption (postimplantation loss) was observed at 100 mg/kg/day and decreased fetal weight was observed at both 30 mg/kg/day and 100 mg/kg/day. A value of zero indicates that no data are available.